If a variant has more than one submission, it may be counted in more than one significance column. If this is the
case, the total number of variants will be less than the sum of the other cells.
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
total |
68
|
64
|
23
|
0 |
0 |
154
|
Gene and significance breakdown #
Total genes and gene combinations: 80
Gene or gene combination |
pathogenic |
likely pathogenic |
uncertain significance |
total |
TBX6
|
3
|
3
|
7
|
13
|
FBN1
|
4
|
2
|
6
|
12
|
ROR2
|
0 |
2
|
10
|
11
|
MYH3
|
0 |
9
|
0 |
9
|
PTPN11
|
4
|
3
|
0 |
7
|
NF1
|
5
|
1
|
0 |
6
|
ACAN
|
2
|
1
|
0 |
3
|
BLM
|
3
|
0 |
0 |
3
|
CUL7
|
2
|
1
|
0 |
3
|
PHEX
|
3
|
0 |
0 |
3
|
ANKRD11
|
2
|
0 |
0 |
2
|
ASXL1
|
0 |
2
|
0 |
2
|
COL11A1
|
1
|
1
|
0 |
2
|
COL2A1
|
0 |
2
|
0 |
2
|
COMP
|
1
|
1
|
0 |
2
|
FGFR3
|
1
|
1
|
0 |
2
|
GH-LCR, GH1
|
0 |
2
|
0 |
2
|
GHRHR
|
0 |
2
|
0 |
2
|
IDS
|
1
|
1
|
0 |
2
|
NPR2
|
0 |
2
|
0 |
2
|
NR0B1
|
2
|
0 |
0 |
2
|
POU1F1
|
0 |
2
|
0 |
2
|
RAF1
|
1
|
1
|
0 |
2
|
SRCAP
|
2
|
0 |
0 |
2
|
AMMECR1
|
0 |
1
|
0 |
1
|
AQP2
|
1
|
0 |
0 |
1
|
ARID1B
|
1
|
0 |
0 |
1
|
ASPM
|
1
|
0 |
0 |
1
|
AVPR2
|
1
|
0 |
0 |
1
|
CDH2
|
0 |
1
|
0 |
1
|
COL10A1, NT5DC1
|
0 |
1
|
0 |
1
|
COL6A3
|
1
|
0 |
0 |
1
|
CTCF
|
1
|
0 |
0 |
1
|
DMD
|
1
|
0 |
0 |
1
|
EGFR
|
0 |
1
|
0 |
1
|
ENG
|
1
|
0 |
0 |
1
|
ERCC6
|
1
|
0 |
0 |
1
|
EVC
|
0 |
1
|
0 |
1
|
EXT1
|
1
|
0 |
0 |
1
|
FGFR1
|
0 |
1
|
0 |
1
|
GALNS
|
0 |
1
|
0 |
1
|
GNPTAB
|
1
|
0 |
0 |
1
|
IDS, LOC106050102
|
1
|
0 |
0 |
1
|
IGF1R
|
0 |
1
|
0 |
1
|
IL17RD
|
0 |
1
|
0 |
1
|
KMT2A
|
1
|
0 |
0 |
1
|
LEMD3
|
1
|
0 |
0 |
1
|
LOC123956210, SLC26A4
|
0 |
1
|
0 |
1
|
LOC126807619, NSD1
|
1
|
0 |
0 |
1
|
LOC126861318, MMP13
|
0 |
1
|
0 |
1
|
LOC130060295, MYH3
|
0 |
1
|
0 |
1
|
MAP2K1
|
0 |
1
|
0 |
1
|
MAP4K4
|
0 |
1
|
0 |
1
|
NRIP3-DT, SCUBE2
|
0 |
1
|
0 |
1
|
OBSL1
|
1
|
0 |
0 |
1
|
OFD1
|
1
|
0 |
0 |
1
|
OFD1, TRAPPC2
|
0 |
1
|
0 |
1
|
ORC1
|
0 |
1
|
0 |
1
|
PIEZO2
|
0 |
1
|
0 |
1
|
PITPNM3
|
1
|
0 |
0 |
1
|
PLA2G6
|
1
|
0 |
0 |
1
|
PORCN
|
1
|
0 |
0 |
1
|
PREX2
|
0 |
1
|
0 |
1
|
RECQL4
|
1
|
0 |
0 |
1
|
RIT1
|
1
|
0 |
0 |
1
|
SARS1
|
1
|
0 |
0 |
1
|
SETD5
|
1
|
0 |
0 |
1
|
SLC7A7
|
1
|
0 |
0 |
1
|
SOS2
|
1
|
0 |
0 |
1
|
SPRED1
|
1
|
0 |
0 |
1
|
SRD5A2
|
1
|
0 |
0 |
1
|
STAT5B
|
0 |
1
|
0 |
1
|
SUCLG1
|
1
|
0 |
0 |
1
|
SYN3, TIMP3
|
0 |
1
|
0 |
1
|
TINF2
|
0 |
1
|
0 |
1
|
TMEM67
|
0 |
1
|
0 |
1
|
TRPS1
|
0 |
1
|
0 |
1
|
VPS13B
|
1
|
0 |
0 |
1
|
ZFYVE16
|
0 |
1
|
0 |
1
|
ZMYND11
|
1
|
0 |
0 |
1
|
Condition and significance breakdown #
Condition |
pathogenic |
likely pathogenic |
uncertain significance |
total |
Scoliosis
|
3
|
3
|
7
|
13
|
Cerebral arteriovenous malformation
|
4
|
8
|
0 |
12
|
Short stature
|
0 |
1
|
10
|
11
|
MYH3-related disorder
|
0 |
10
|
0 |
10
|
Congenital scoliosis
|
2
|
0 |
6
|
8
|
Noonan syndrome 1
|
4
|
3
|
0 |
7
|
Neurofibromatosis, type 1
|
5
|
1
|
0 |
6
|
3M syndrome 1
|
2
|
1
|
0 |
3
|
Bloom syndrome
|
3
|
0 |
0 |
3
|
Familial X-linked hypophosphatemic vitamin D refractory rickets
|
3
|
0 |
0 |
3
|
Mucopolysaccharidosis, MPS-II
|
2
|
1
|
0 |
3
|
Osteochondritis dissecans
|
2
|
1
|
0 |
3
|
Autosomal dominant isolated somatotropin deficiency
|
0 |
2
|
0 |
2
|
Bohring-Opitz syndrome
|
0 |
2
|
0 |
2
|
Congenital adrenal hypoplasia, X-linked
|
2
|
0 |
0 |
2
|
Floating-Harbor syndrome
|
2
|
0 |
0 |
2
|
Hypochondroplasia
|
1
|
1
|
0 |
2
|
Isolated growth hormone deficiency, type 4
|
0 |
2
|
0 |
2
|
KBG syndrome
|
2
|
0 |
0 |
2
|
Marshall syndrome
|
1
|
1
|
0 |
2
|
Noonan syndrome 5
|
1
|
1
|
0 |
2
|
Pituitary hormone deficiency, combined, 1
|
0 |
2
|
0 |
2
|
Short stature with nonspecific skeletal abnormalities
|
0 |
2
|
0 |
2
|
3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency
|
1
|
0 |
0 |
1
|
3M syndrome 2
|
1
|
0 |
0 |
1
|
Brachydactyly type B1
|
0 |
1
|
0 |
1
|
Cardiofaciocutaneous syndrome 3
|
0 |
1
|
0 |
1
|
Cerebrooculofacioskeletal syndrome 1
|
1
|
0 |
0 |
1
|
Coffin-Siris syndrome 1
|
1
|
0 |
0 |
1
|
Cohen syndrome
|
1
|
0 |
0 |
1
|
Curry-Hall syndrome
|
0 |
1
|
0 |
1
|
Diabetes insipidus, nephrogenic, X-linked
|
1
|
0 |
0 |
1
|
Diabetes insipidus, nephrogenic, autosomal
|
1
|
0 |
0 |
1
|
Duchenne muscular dystrophy
|
1
|
0 |
0 |
1
|
Dyskeratosis congenita, autosomal dominant 3
|
0 |
1
|
0 |
1
|
Focal dermal hypoplasia
|
1
|
0 |
0 |
1
|
Geleophysic dysplasia 2
|
0 |
1
|
0 |
1
|
Gordon syndrome
|
0 |
1
|
0 |
1
|
Growth delay due to insulin-like growth factor I resistance
|
0 |
1
|
0 |
1
|
Growth hormone insensitivity with immune dysregulation 1, autosomal recessive
|
0 |
1
|
0 |
1
|
Hypogonadotropic hypogonadism 2 with or without anosmia
|
0 |
1
|
0 |
1
|
Infantile neuroaxonal dystrophy
|
1
|
0 |
0 |
1
|
Intellectual disability, autosomal dominant 30
|
1
|
0 |
0 |
1
|
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency
|
1
|
0 |
0 |
1
|
Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome
|
1
|
0 |
0 |
1
|
Joubert syndrome 6
|
0 |
1
|
0 |
1
|
Legius syndrome
|
1
|
0 |
0 |
1
|
Lysinuric protein intolerance
|
1
|
0 |
0 |
1
|
MASS syndrome
|
0 |
1
|
0 |
1
|
Marfan syndrome
|
1
|
0 |
0 |
1
|
Meier-Gorlin syndrome 1
|
0 |
1
|
0 |
1
|
Metaphyseal chondrodysplasia, Schmid type
|
0 |
1
|
0 |
1
|
Microcephaly 5, primary, autosomal recessive
|
1
|
0 |
0 |
1
|
Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis
|
0 |
1
|
0 |
1
|
Mitochondrial DNA depletion syndrome 9
|
1
|
0 |
0 |
1
|
Mucopolysaccharidosis, MPS-IV-A
|
0 |
1
|
0 |
1
|
Multiple congenital exostosis
|
1
|
0 |
0 |
1
|
Multiple epiphyseal dysplasia type 1
|
1
|
0 |
0 |
1
|
Noonan syndrome 8
|
1
|
0 |
0 |
1
|
Noonan syndrome 9
|
1
|
0 |
0 |
1
|
Orofaciodigital syndrome I
|
1
|
0 |
0 |
1
|
Pendred syndrome
|
0 |
1
|
0 |
1
|
Progeroid and marfanoid aspect-lipodystrophy syndrome
|
1
|
0 |
0 |
1
|
Pseudo-Hurler polydystrophy
|
1
|
0 |
0 |
1
|
Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome
|
0 |
1
|
0 |
1
|
Rothmund-Thomson syndrome type 2
|
1
|
0 |
0 |
1
|
Sotos syndrome
|
1
|
0 |
0 |
1
|
Spondyloepimetaphyseal dysplasia, Missouri type
|
0 |
1
|
0 |
1
|
Spondyloepiphyseal dysplasia congenita
|
0 |
1
|
0 |
1
|
Spondyloepiphyseal dysplasia tarda
|
0 |
1
|
0 |
1
|
Spondyloperipheral dysplasia
|
0 |
1
|
0 |
1
|
Trichorhinophalangeal dysplasia type I
|
0 |
1
|
0 |
1
|
Ullrich congenital muscular dystrophy 1A
|
1
|
0 |
0 |
1
|
Wiedemann-Steiner syndrome
|
1
|
0 |
0 |
1
|
The information on this website is not intended for direct
diagnostic use or medical decision-making without review by a
genetics professional. Individuals should not change their
health behavior solely on the basis of information contained on
this website. Neither the University of Utah nor the National
Institutes of Health independently verfies the submitted
information. If you have questions about the information
contained on this website, please see a health care
professional.